What is Regenxbio's R&D?

Regenxbio (RGNX) reported R&D of $57.34M in Q1 2026.

How has Regenxbio's R&D changed year-over-year?

Regenxbio's R&D increased by 8.0% year-over-year, from $53.09M to $57.34M.

What is the long-term trend for Regenxbio's R&D?

Over 4 years (2021 to 2025), Regenxbio's R&D has grown at a 5.9% compound annual growth rate (CAGR), from $181.44M to $228.3M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Regenxbio RGNX R&D

R&D at other companies

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

BiogenBIIB

$539M+24.2%

BioMarin PharmaceuticalsBMRN

$178.8M+12.6%

EyePoint, Inc. EYPT

$72.15M+23.2%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

4D Molecular TherapeuticsFDMT

$64.98M+59.7%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's R&D?: Regenxbio (RGNX) reported R&D of $57.34M in Q1 2026.
How has Regenxbio's R&D changed year-over-year?: Regenxbio's R&D increased by 8.0% year-over-year, from $53.09M to $57.34M.
What is the long-term trend for Regenxbio's R&D?: Over 4 years (2021 to 2025), Regenxbio's R&D has grown at a 5.9% compound annual growth rate (CAGR), from $181.44M to $228.3M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.